Free Newsletter
Grassley: Whistleblowers, call me
Scientists, Senator Charles Grassley (R-IA) wants you. Yesterday on the Senate floor, Grassley rehashed some old pharma company-intimidating-scientist cases--including Merck on Vioxx and GlaxoSmithKline on Avandia. This is old news to anyone in pharma and most everyone else who reads the news daily. But it doesn't matter, because it was just bait.
Grassley wants any would-be whistleblowers to call his office. He also solicited contact from scientists whose employers bully them into suppressing data. Anonymous tips are OK, too, he said. Just call. Even better, fax secret documents to 202-228-2131. Any bets on how many calls he'll get?
- see Grassley's floor statement for more
Related Articles:
FDA's showdown with Grassley to delay nomination. Report
Grassley investigates Medicaid drug claims. Report
Comments
Post new comment
Paid Research Reports
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities
- Investigating Clinical Trial Costs: Comparative analysis of trial cost components in key geographies
- Clinical Trial Recruitment Strategies: Optimizing patient recruitment and retention in late stage clinical trials
- Pipeline Insight: Therapeutic Cancer Vaccines - Prospect of first approval set to reinvigorate interest from major companies
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession
SHARE
WITH: